| |
 |
|
Class Information
Number: 514/266.3
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) > 1,3-diazines (e.g., pyrimidines, etc.) > Polycyclo ring system having 1,3-diazine as one of the cyclos > Bicyclo ring system having the 1,3-diazine as one of the cyclos > Quinazoline (including hydrogenated)(i.e., the second cyclo in the bicyclo ring system is an ortho-fused six-membered carbocycle) > Chalcogen bonded directly to a ring carbon of the 1,3-diazine ring of the quinazoline ring system
Description: Subject matter wherein a ring carbon of the 1,3-diazine ring of the quinazoline ring system is directly bonded to a chalcogen (i.e., oxygen, sulfur, selenium, or tellurium).
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 8658656 |
Methods and compositions utilizing quinazolinones |
Feb. 25, 2014 |
| 8633211 |
Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions |
Jan. 21, 2014 |
| 8623884 |
Quinazolinedione derivatives as PARP inhibitors |
Jan. 7, 2014 |
| 8609674 |
Potassium channel modulators |
Dec. 17, 2013 |
| 8609667 |
E-type phenyl acrylic ester compounds containing substituted anilino pyrimidine group and uses thereof |
Dec. 17, 2013 |
| 8586597 |
6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta |
Nov. 19, 2013 |
| 8575185 |
Compositions, synthesis, and methods of utilizing quinazolinedione derivatives |
Nov. 5, 2013 |
| 8551950 |
Method of treatment or prophylaxis of inflammatory pain |
Oct. 8, 2013 |
| 8552015 |
Quinazolinone derivatives and their use as CB agonists |
Oct. 8, 2013 |
| 8524721 |
Platelet ADP receptor inhibitors |
Sep. 3, 2013 |
| 8518960 |
Antiviral drugs for treatment or prevention of dengue infection |
Aug. 27, 2013 |
| 8518441 |
Solid dispersions or solid dispersion pharmaceutical preparations of phenylalanine derivatives |
Aug. 27, 2013 |
| 8513268 |
1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy |
Aug. 20, 2013 |
| 8507502 |
Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors |
Aug. 13, 2013 |
| 8475776 |
Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis |
Jul. 2, 2013 |
| 8470838 |
Methods and compositions utilizing quinazolinones |
Jun. 25, 2013 |
| 8445491 |
Wnt protein signalling inhibitors |
May. 21, 2013 |
| 8431585 |
Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH)/prostatic hypertrophy |
Apr. 30, 2013 |
| 8372856 |
Hydrates of erlotinib hydrochloride |
Feb. 12, 2013 |
| 8349852 |
Quinazolinone derivatives useful as vanilloid antagonists |
Jan. 8, 2013 |
| 8349857 |
Quinazoline derivatives having tyrosine kinase inhibitory activity |
Jan. 8, 2013 |
| 8349850 |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
Jan. 8, 2013 |
| 8329713 |
Fused ring heterocycles as potassium channel modulators |
Dec. 11, 2012 |
| 8309561 |
Phenylalanine derivatives |
Nov. 13, 2012 |
| 8299085 |
Quinazoline derivatives |
Oct. 30, 2012 |
| 8268844 |
Crystals of isopropyl ester of N-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl-1-methyl-2,4-dioxo-1,4-d- ihydroquinazoline-3(2H)-yl]-l-phenylalanine hydrochloride, production method thereo |
Sep. 18, 2012 |
| 8268843 |
5,8-difluoro-4-(2-(4-(heteroaryloxy)-phenyl)ethylamino)quinazolines and their use as agrochemicals |
Sep. 18, 2012 |
| 8268842 |
Fused ring 4-oxopyrimidine derivative |
Sep. 18, 2012 |
| 8242126 |
Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof |
Aug. 14, 2012 |
| 8232285 |
Quinazolinone compounds and methods of use thereof |
Jul. 31, 2012 |
| 8222264 |
Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture |
Jul. 17, 2012 |
| 8211901 |
Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors |
Jul. 3, 2012 |
| 8211902 |
Quinazolinone derivatives useful as vanilloid antagonists |
Jul. 3, 2012 |
| 8202879 |
Quinazoline derivatives having tyrosine kinase inhibitory activity |
Jun. 19, 2012 |
| 8188103 |
Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors |
May. 29, 2012 |
| 8178544 |
2, 3-diamino-quinazolinone derivatives and their medical use |
May. 15, 2012 |
| 8101624 |
Quinazoline derivatives |
Jan. 24, 2012 |
| 8084459 |
Substituted quinazolinones for treating neurological conditions |
Dec. 27, 2011 |
| 8067436 |
c-Met modulators and methods of use |
Nov. 29, 2011 |
| 8030320 |
Derivatives of 1-OXO-1,2-dihydroisoquinoline-5-carboxamides and of 4-OXO-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
Oct. 4, 2011 |
| 8012988 |
N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-q- uinazolin-3-yl)methanesulfonamide |
Sep. 6, 2011 |
| 8008311 |
Methods and compostions utilizing quinazolinones |
Aug. 30, 2011 |
| 7994182 |
Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having PARP enzyme inhibitory effect |
Aug. 9, 2011 |
| 7951814 |
Quinazolinedione derivatives as TRPA1 modulators |
May. 31, 2011 |
| 7951813 |
Quinazolinone derivatives as ALDH-2 inhibitors |
May. 31, 2011 |
| 7939539 |
Quinazolinone compounds as anticancer agents |
May. 10, 2011 |
| 7935709 |
2-quinazolinone compounds and methods of use |
May. 3, 2011 |
| 7928114 |
Crystalline erlotinib |
Apr. 19, 2011 |
| 7893071 |
Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |
Feb. 22, 2011 |
| 7863283 |
Sulphoximine-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments |
Jan. 4, 2011 |
|
|
|
